According to the American Cancer Society, over 21,000 new cases of ovarian cancer are diagnosed each year with 15,000 more women dying annually. What are the recent developments in research to improve these odds?  Dr. Robert Bristow, the director of the Kelly Gynecologic Oncology Service and the Johns Hopkins Ovarian Cancer Center of Excellence, joins host Dr. Leslie Lundt to discuss the value of debulking surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.

Click here to access the interview:

After you clink on the link, register on the website and you will be able to hear the interview.